LENZ Therapeutics, Inc. (LENZ)

NASDAQ: LENZ · Real-Time Price · USD

12.15

+0.33 (2.79%)

At close: Mar 13, 2026, 4:00 PM EDT

12.14

-0.01 (-0.08%)

After-hours: Mar 13, 2026, 6:51 PM EDT

LENZ Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	25.4	20.16	35.14	47.73	376.98	19.78
Short-Term Investments	176.77	188.87	30.65	220.5	-	-
Cash & Short-Term Investments	202.17	209.03	65.79	268.23	376.98	19.78
Cash Growth	-6.88%	217.70%	-75.47%	-28.85%	1805.65%	329600.00%
Inventory	0.95	-	-	-	-	-
Other Current Assets	3.88	2.89	1.45	7.14	4.76	1.32
Total Current Assets	207	211.92	67.24	275.37	381.74	21.1
Net Property, Plant & Equipment	2.11	1.99	0.37	28.21	18.08	1.46
Long-Term Investments	-	-	-	15.32	-	-
Other Long-Term Assets	1.6	1.4	2.76	3.01	2.17	-
Total Assets	210.7	215.3	70.38	321.9	401.99	22.56
Accounts Payable	4.32	4.26	5.71	2.61	2.45	0.63
Accrued Expenses	11.99	6.15	12.8	6.39	4.21	2.36
Current Portion of Leases	-	-	-	4.05	5.48	-
Other Current Liabilities	-	-	-	-	-	29.06
Total Current Liabilities	16.32	10.41	18.51	13.04	12.14	32.05
Long-Term Leases	0.46	0.81	0.19	1.75	5.79	-
Other Long-Term Liabilities	-	-	0.99	10.82	-	0.32
Total Long-Term Liabilities	0.46	0.81	1.18	12.57	5.79	0.32
Total Liabilities	16.78	11.22	19.7	25.61	17.94	32.36
Common Stock	0	0	5.91	0	0	0
Additional Paid-in Capital	384.94	348.9	2.52	539.74	525.4	5.18
Accumulated Other Comprehensive Income	0.23	0.2	0.01	-1.05	-	-
Retained Earnings	-191.25	-145.01	-95.25	-242.4	-141.35	-70.59
Total Common Shareholders' Equity	193.93	204.08	-86.81	296.29	384.05	-65.41
Minority Interest	-	-	137.49	-	-	55.61
Shareholders' Equity	193.93	204.08	50.68	296.29	384.05	-9.8
Total Liabilities & Equity	210.7	215.3	70.38	321.9	401.99	22.56
Total Debt	0.46	0.81	0.19	5.79	11.28	0
Net Cash (Debt)	201.71	208.22	65.6	262.44	365.7	19.78
Net Cash Growth	-3.12%	217.39%	-75.00%	-28.24%	1748.65%	-
Net Cash Per Share	7.23	9.78	33.49	31.61	88.52	60.63
Book Value	193.93	204.08	-86.81	296.29	384.05	-65.41
Book Value Per Share	6.95	9.59	-44.31	35.68	92.96	-200.45
Tangible Book Value	193.93	204.08	-86.81	296.29	384.05	-65.41
Tangible Book Value Per Share	6.95	9.59	-44.31	35.68	92.96	-200.45

Updated Nov 5, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q